Beta-herpesvirus challenges in the transplant recipient.
about
Amplification of autoimmune disease by infectionDetection and Typing of Human Herpesvirus 6 by Molecular Methods in Specimens from Patients Diagnosed with Encephalitis or MeningitisRoseolovirus-associated encephalitis in immunocompetent and immunocompromised individuals.T-bet:Eomes balance, effector function, and proliferation of cytomegalovirus-specific CD8+ T cells during primary infection differentiates the capacity for durable immune control.Primary cytomegalovirus phosphoprotein 65-specific CD8+ T-cell responses and T-bet levels predict immune control during early chronic infection in lung transplant recipients.Management of infectious complications in the hematopoietic stem cell transplant recipient.Risk of cytomegalovirus transmission by blood products to immunocompromised patients and means for reduction.Simultaneous human herpesvirus 6-associated encephalitis and Guillain-Barré syndrome in a patient after matched unrelated donor haematopoietic stem cell transplantationOptimisation of a quantitative polymerase chain reaction-based strategy for the detection and quantification of human herpesvirus 6 DNA in patients undergoing allogeneic haematopoietic stem cell transplantation.IL-12-Dependent Cytomegalovirus-Specific CD4+ T Cell Proliferation, T-bet Induction, and Effector Multifunction during Primary Infection Are Key Determinants for Early Immune Control.Mechanisms and consequences of persistence of intracellular pathogens: leishmaniasis as an example.High-quality CMV-specific CD4+ memory is enriched in the lung allograft and is associated with mucosal viral controlManipulation of dendritic cell functions by human cytomegalovirus.Engineering of a chimeric RB69 DNA polymerase sensitive to drugs targeting the cytomegalovirus enzyme.Oral activity of a methylenecyclopropane analog, cyclopropavir, in animal models for cytomegalovirus infections.Role for tumor necrosis factor alpha in murine cytomegalovirus transcriptional reactivation in latently infected lungs.Chronic and recurrent benign lymphadenopathy without constitutional symptoms associated with human herpesvirus-6B reactivation.Limbic Encephalitis Associated with Human Herpesvirus-7 (HHV-7) in an Immunocompetent Adult: The First Reported Case in Japan.Infection with human herpesvirus 6 after kidney-pancreas transplant.Quantitative polymerase chain reaction for detection of human herpesvirus-7 infection in umbilical cord blood donors.Late onset epstein barr virus seropositive posttransplant lymphoproliferative disorder in two renal transplant receivers.UL54 foscarnet mutation in an hematopoietic stem cell transplant recipient with cytomegalovirus disease.Molecular interactions between porcine and human gammaherpesviruses: implications for xenografts?Human herpesvirus 6 antigenaemia in allogeneic stem cell transplant recipients: impact on clinical course and association with other beta-herpesviruses.GMP-production of purified human B lymphocytes for the adoptive transfer in patients after allogeneic hematopoietic stem cell transplantation.American Society of Transplantation recommendations for screening, monitoring and reporting of infectious complications in immunosuppression trials in recipients of organ transplantation.Human herpesvirus 6 infection arrests cord blood mononuclear cells in G(2) phase of the cell cycle.A case of drug-induced hypersensitivity syndrome showing transient immunosuppression before viral reactivation during treatment for pemphigus foliaceus.Valganciclovir as treatment for cytomegalovirus disease in solid organ transplant recipients.Oral valganciclovir as pre-emptive therapy has similar efficacy on cytomegalovirus DNA load reduction as intravenous ganciclovir in allogeneic stem cell transplantation recipients.Viral infection in renal transplant recipients.HHV-6 and atypical lymphoproliferative disorders: are only qualitative molecular examinations sufficient to support a pathogenetic role?
P2860
Q24804390-A57F9CAE-27C9-463E-9A70-204D7D12C9A5Q27484911-364054CD-8E7F-4ACF-B9B0-CFD74F2D1E50Q34537814-0B4D0471-554F-4799-A4A0-45202306E57DQ34550760-1749CDA0-123D-420A-A6EB-B392BD19846EQ35463623-99A48569-AEE6-4FA0-B4F6-FE6201B6D46DQ35675979-F8E749CE-B8EB-4D50-B3DE-41EAA4C6DC91Q35732096-0248336B-AACD-4A15-891F-A5E47AB95BABQ35762061-9D086693-FB51-48E3-B11C-FFBD91AF820CQ35849274-C62DBD1B-B1F4-4968-BD39-5E936B749B71Q36447548-85521390-A79A-4381-838F-ACF1CC35B271Q37118101-0B900048-8E7C-4BFA-9A07-794E14508A33Q37308147-13AA9B4F-E181-4961-8617-A1243B425177Q37331842-176CE7A1-6D6D-4D0F-9B43-8484941304F5Q37446675-0EBE2F39-BDF2-485A-B98E-D2F2F7A8D566Q37624896-CB0247D4-E429-408F-BF84-6E607FF829AAQ37747368-83968CD2-6D4F-486A-B20B-D92D91E534BFQ38930292-641FFBAF-2E1A-43F1-9BFB-BA891AF89D91Q40047843-BD85264F-0379-442C-A2E9-7E9F09C7C6E2Q40531969-5DC53DAC-8E29-4C30-8B8C-F174850C4E3DQ41640169-52536E35-FA50-40CE-8BD2-520C0CF29AC9Q41846519-6F4BC0DD-55B7-4A08-823F-7850E75182CAQ42224425-B45B4100-3E16-4B53-BC5A-6FA650C94397Q43220723-27002DA3-2E2B-414A-9A13-7E1DABD5B126Q43636855-32E202ED-B37A-4766-9316-49A9D3675BA9Q44456961-44D54ECF-CCEC-4BBB-A6FC-77E2BC594D5EQ44495127-956F7E66-4754-4F0F-A7A5-6770DD7FF5E2Q44779055-6B5572F8-BC34-40E1-8648-202E8A650B14Q46821399-98F66F1A-E26F-4909-95A7-A1993241BEA0Q46826218-B07B1812-E009-420A-81F7-91DA924F50EBQ46963345-59A86A74-0D45-4822-9D0C-045145AF94E6Q51594265-91109DE3-148F-4EF1-ACEC-5B3B844A432AQ54442287-8B2A09FC-119B-497B-BBC4-82EF245588D1
P2860
Beta-herpesvirus challenges in the transplant recipient.
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Beta-herpesvirus challenges in the transplant recipient.
@ast
Beta-herpesvirus challenges in the transplant recipient.
@en
Beta-herpesvirus challenges in the transplant recipient.
@nl
type
label
Beta-herpesvirus challenges in the transplant recipient.
@ast
Beta-herpesvirus challenges in the transplant recipient.
@en
Beta-herpesvirus challenges in the transplant recipient.
@nl
prefLabel
Beta-herpesvirus challenges in the transplant recipient.
@ast
Beta-herpesvirus challenges in the transplant recipient.
@en
Beta-herpesvirus challenges in the transplant recipient.
@nl
P2860
P356
P1476
Beta-herpesvirus challenges in the transplant recipient.
@en
P2093
Per Ljungman
P2860
P304
P356
10.1086/342962
P407
P478
186 Suppl 1
P577
2002-10-01T00:00:00Z